Skip to main content
. 2021 Sep 20;118(39):e2102715118. doi: 10.1073/pnas.2102715118

Fig. 6.

Fig. 6.

Targeting IL-17A in frozen shoulder. Schematic diagram illustrating possible IL-17A–driven pathogenesis in frozen shoulder. The presence of IL-17A–secreting T cells results in the fibrosis, inflammation, and further recruitment of pathogenic T cells, resulting in disease chronicity, which can be attenuated by use of an anti–IL-17A monoclonal antibody.